SB17: Bill Text

SB17,21,22 (f) Restrict directly the freedom of hospitals to exercise management decisions in complying with the rates established by the commission, unless a hospital agrees to a condition attached to the establishment of particular rates.

SB17,21,24 (g) Require the submission of unrelated financial data from religious groups affiliated with a hospital.

SB17,22,3 196.9991 Injunctions of commission orders. No injunction may be issued to suspend or stay enforcement of an order of the commission unless all of the following occur:

SB17,22,7 (1) All parties to the proceeding from which the commission's order was issued are notified of the petition seeking an injunction, are given an opportunity to appear at a hearing prior to the issuance of the injunction and are made parties to the proceeding in circuit court.

SB17,22,12 (2) The party seeking the injunction enters into an undertaking by at least 2 sureties at a level that the circuit court finds sufficient to guarantee the payment of all damages the hospital may sustain by delaying the effect of the commission's order. This subsection does not apply to a hospital that was a party to the proceeding from which the commission's order was issued.

SB17,22,15 196.9992 Expedited review, expedited cases and exempt hospitals. (1) The commission may promulgate rules under which hospitals meeting specific criteria receive expedited review of rate requests under this subchapter.

SB17,22,18 (2) (a) A hospital whose gross annual patient revenue is less than $10,000,000, adjusted as provided in s. 196.9995, for the hospital's last fiscal year is eligible to receive automatic approval of its rate request if it meets all of the following criteria:

SB17,22,20 1. The commission has conducted a complete review of the hospital's rates and has set the hospital's rates in a preceding year.

SB17,22,23 2. The hospital requests a rate increase that is less than an inflationary index consisting of the average of the consumer price index and the hospital market basket index.

SB17,23,3 (b) Any hospital that receives automatic approval of its rate request under this subsection shall publish as a class 1 notice under ch. 985, in one or more newspapers likely to give notice to its patients and payers, a list of the price adjustments it is making to 100 of its charge elements as specified by the commission. The hospital shall publish this notice prior to implementing its rate increase.

SB17,23,5 (c) The commission may, by rule, extend automatic approval status under this subsection to other hospitals.

SB17,23,10 (2m) The commission may grant hospitals whose gross annual patient revenue is less than $10,000,000, adjusted as provided in s. 196.9995, a rate increase that takes effect over a 2-year period with an automatic escalation clause taking effect at the end of the first year. A hospital that receives a 2-year rate increase is not required to request a rate increase at the end of the first year.

SB17,23,12 (3) Any judicial proceeding affecting a rule or decision of the commission shall be heard and determined as expeditiously as possible.

SB17,23,16 196.9993 Utilization review program. (1) The commission shall approve an all-patient utilization review program for each hospital that shall conform to requirements of federal regulations on utilization review programs. The commission may evaluate these programs as part of its monitoring functions under s. 196.994 (3).

SB17,23,22 (2) The commission shall contract with one or more independent utilization review programs to develop review standards, and the commission may contract with any person to monitor implementation of these programs by hospitals and to perform peer review functions for hospitals that fail to meet the performance standards adopted by the commission. The commission may not contract with state agencies, other than the University of Wisconsin System, under this subsection.

SB17,24,2 (3) Each utilization review program the commission approves shall include a general summary of utilization within the hospital. These programs need not otherwise be identical but shall meet minimum standards established by the commission and shall do all of the following:

SB17,24,4 (a) Evaluate the medical necessity or appropriateness of care relative to admissions, lengths of stay and ancillary services.

SB17,24,7 (b) Report to the commission, in conjunction with each hospital's submission of proposed financial requirements, any findings that it has made regarding unnecessary or inappropriate medical care utilization and associated costs.

SB17,24,12 196.9994 Enforcement. (1) (a) Until the commission establishes different rates under this subchapter, no hospital may charge any payer an amount exceeding the rates established as of the effective date of this paragraph .... [revisor inserts date]. No hospital may charge any payer an amount exceeding the rates established under this subchapter.

SB17,24,19 (b) The attorney general may seek a judicial remedy to enforce compliance with par. (a) if the attorney general first notifies the hospital and provides the hospital a reasonable time to correct a violation. The commission may seek a judicial remedy to enforce compliance with any statutory requirement or with any rule or order of the commission if it first notifies the hospital and provides the hospital a reasonable time to correct a violation. The commission shall commence any action under this paragraph in the circuit court for the county in which the hospital is located.

SB17,24,23 (c) Any court that finds an intentional failure to comply with the rates under this subsection may impose a forfeiture of up to $5,000. Each week that a hospital continues its intentional failure to comply with the rates constitutes a separate violation.

SB17,25,4 (2) Neither a hospital nor a physician may be paid for a service that a utilization review program under s. 196.9993 determines is medically unnecessary or inappropriate. If the hospital or physician has already been paid, the hospital or physician shall reimburse the payer within 30 days. The commission may commence an action to enforce this subsection in the circuit court for the county in which the hospital is located.

SB17,25,7 (3) Any court with jurisdiction over an action brought under this section may adopt remedies that it finds necessary to enforce compliance. Remedies under this section apply notwithstanding the existence or pursuit of any other remedy.

SB17,25,10 (4) Any person who intentionally violates an order of a hearing examiner issued under s. 227.46 (7) to protect trade secrets in a contested case brought under this subchapter shall forfeit $5,000.

SB17,25,14 196.9995 Annual adjustments. The limits on gross annual patient revenue in ss. 196.997 (1) (b) and 196.9992 (2) (a) (intro.) and (2m) shall be adjusted annually to reflect annual changes in the average of the consumer price index and the hospital market basket index.

SB17,25,15 196.9996 Assessments. (1) In this section:

SB17,25,18 (a) "Commercial insurance" includes a group or individual disability insurance policy, as defined in s. 632.895 (1) (a), an employer's self-insured health care plan and worker's compensation.

SB17,25,21 (b) "Deduction" means the portion of a charge that was incurred by a patient but was not received from 3rd-party payers or governmental or private payment. "Deduction" includes charity care but does not include bad debt.

SB17,25,23 (c) "Expense" means the cost of operation, including bad debt, that is charged to a hospital during the hospital's fiscal year.

SB17,26,2 (d) "Gross patient revenue" means the total charges to medicare, as defined in s. 49.498 (1) (f), the medical assistance program, other public programs, commercial insurance and other self-payers or nonpublic payers, that are generated by a hospital from inpatient and outpatient services.

SB17,26,4 (e) "Net income" means total revenue and nonoperating gains in excess of expenses and nonoperating losses.

SB17,26,5 (f) "Net patient revenue" means gross patient revenue minus deductions.

SB17,26,7 (g) "Nonoperating gains" means gifts, donations, endowments, return on investments and any other gains that are not related to patient care.

SB17,26,10 (h) "Nonoperating losses" means state and federal corporate income and real estate taxes and other losses that are not directly related to patient care or hospital-related patient services.

SB17,26,13 (i) "Other public programs" include programs operated by or contracted for by county departments under s. 46.215, 46.22 or 46.23 and the relief program under ch. 49.

SB17,26,16 (j) "Other revenue" means revenue from services, other than health care services, provided to patients and revenue from sales to and services provided to nonpatients.

SB17,26,17 (k) "Total revenue" means the sum of net patient revenue and other revenue.

SB17,27,3 (2) Beginning July 1, 1998, the commission shall, within 90 days after the commencement of each fiscal year, estimate the total amount of revenue required for administration by the commission of this subchapter during that fiscal year and assess that estimated total amount to hospitals, under the rates established by rule under s. 196.993 (2) and in proportion to each hospital's respective net income during the hospital's most recently concluded entire fiscal year. The commission may not assess under this subsection a hospital that has a net income of 3% or less over the net income for the hospital's next most recently concluded entire fiscal year. Each hospital that is assessed shall pay the assessment by the December 1 following the assessment. The commission shall credit all payments of assessments to the appropriation account under s. 20.155 (3) (gm).

SB17,27,6 196.9998 Capital expenditure review program. (1) Applicability. Beginning on July 1, 1998, no person may do any of the following without first obtaining the commission's approval:

SB17,27,14 (a) Except as provided in sub. (2), obligate for a capital expenditure, by or on behalf of a hospital, that exceeds $1,000,000. The cost of the studies, surveys, plans and other activities essential to the proposed capital expenditure shall be included in determining the value of the capital expenditure. Any donation of equipment or facilities that, if acquired directly, would be subject to review under this section is a capital expenditure. Any transfer of equipment or facilities for less than fair market value that, if transferred at fair market value, would be subject to review under this section is a capital expenditure.

SB17,27,19 (b) Implement services new to the hospital that exceed $500,000 in a 12-month period, including an organ transplant program, burn center, neonatal intensive care program, cardiac program or air transport services; implement other services or programs specified by the commission by rule; or add psychiatric or chemical dependency beds.

SB17,27,23 (c) Obligate for an expenditure by or on behalf of a hospital, independent practitioner, limited liability company, partnership, unincorporated medical group or service corporation, as defined in s. 180.1901 (2), that exceeds $500,000 for clinical medical equipment.

SB17,27,24 (d) Purchase or otherwise acquire a hospital.

SB17,27,25 (e) Construct or operate an ambulatory surgery center or a home health agency.

SB17,28,4 (2) Exemptions from capital expenditure review. (a) Subsection (1) does not apply if a person has, prior to the effective date of this subsection .... [revisor inserts date], entered into a legally enforceable contract, promise or agreement with another to do any of the activities specified in sub. (1) (a) to (e).

SB17,28,11 (b) A person may obligate for a capital expenditure by or on behalf of a hospital without obtaining the approval of the commission if the expenditure is for heating, air conditioning, ventilation, electrical systems, energy conservation, telecommunications, computer systems or nonsurgical outpatient services, unless any such expenditure is a constituent of another project reviewable under sub. (1) or unless any such expenditure would exceed 20% of a hospital's gross annual patient revenue for its last fiscal year.

SB17,28,12 (3) Innovative medical technology exemption. (a) In this subsection:

SB17,28,17 1. "Clinical trial" means clinical research conducted under approved protocols in compliance with federal requirements applicable to investigations involving human subjects, including the requirement for an informed consent advising the patient clearly of the risks associated with participating in the clinical development and evaluation project.

SB17,28,20 2. "Innovative medical technology" means equipment or procedures that are potentially useful for diagnostic or therapeutic purposes and that introduce new technology in the diagnosis and treatment of illness.

SB17,28,25 (b) The commission may grant an exemption from the requirements of approval under this section for the research, development and evaluation of innovative medical technology, the development of the clinical applications of this technology or the research, development and evaluation of a major enhancement to existing medical technology if all of the following occur:

SB17,29,3 1. The commission receives an application for an exemption from a person intending to undertake a capital expenditure in excess of $500,000 or intending to undertake a substantial change in a health service.

SB17,29,7 2. Prior to applying for an exemption, preliminary animal studies or preliminary clinical investigation establishes that the innovative medical technology or major enhancement to existing medical technology has a reasonable probability of advancing clinical diagnosis or therapy.

SB17,29,10 3. In the development and evaluation of the clinical applications, the applicant undertakes scientifically sound studies to determine clinical efficacy, safety, cost-effectiveness and appropriate utilization levels in a clinical setting.

SB17,29,14 4. The clinical trials, evaluation or research are conducted according to scientifically sound protocols subject to peer review and approval in accord with the requirements applicable to investigations and clinical evaluation involving human subjects.

SB17,29,16 5. The innovative medical technology is being installed to conduct necessary research, development and evaluation.

SB17,29,22 6. The applicant does not include any recovery of capital expenses incurred as part of an exemption under this subsection in its expense and revenue budget for purposes of rate setting until the applicant receives the approval of the federal food and drug administration and of the commission under this section for general medical use. The applicant may recover operating expenses only after all of the following occur:

SB17,29,23 a. Approval by the federal food and drug administration for safety and efficacy.

SB17,29,24 b. A 3rd party agrees to pay for these expenses.

SB17,30,3 (c) The commission may not grant more than 2 exemptions for any particular type of innovative medical technology or for any particular major enhancement to existing medical technology.

SB17,30,9 (4) Public hearing requirement. (a) Any person intending to undertake a project or activity subject to this section shall cause to be published a class 1 notice under ch. 985 in the official newspaper designated under s. 985.04 or 985.05 or, if none exists, in a newspaper likely to give notice in the area of the proposed project or activity. The notice shall describe the proposed project or activity and describe the time and place for the public hearing required under par. (b).

SB17,30,22 (b) No sooner than 30 days after the date of publication of the notice under par. (a), the person shall conduct a public hearing on the proposed project or activity. The hearing shall be on the expected impact of the proposed project or activity on health care costs, the expected improvement, if any, in the local health care delivery system, and any other issue related to the proposed project or activity. Management staff, if any, of the person seeking to undertake the project or activity and, if possible, at least 3 members of the governing board of a not-for-profit health care provider, if any, seeking to undertake the project or activity shall attend the public hearing to review public testimony. The person seeking to undertake the project or activity shall record accurate minutes of the meeting, shall include copies of the minutes and any written testimony presented at the hearing in an application concerning the project or activity that is submitted under sub. (7) and shall submit the application within 10 days after the date of the public hearing.

SB17,31,2 (5) Notification requirement. Any person intending to undertake a project subject to this section shall notify the commission in writing of this intent at least 30 days prior to submitting an application for review. Any application expires unless the commission declares it complete within one year after the date the applicant notifies the commission of its intent to undertake the project.

SB17,31,7 (6) Application fee. Each application for review of a project or activity subject to this section shall be accompanied by a fee that is established in rules promulgated by the commission. The commission shall promulgate rules that establish application fees that are sufficient to fund all of the commission's expenses under this section.

SB17,31,14 (7) Review requirements. (a) The commission's review of an application begins on the date that it receives a completed application, including the fee under sub. (6). On or before the 20th day of the month following receipt of a completed application, the commission shall send a notice of receipt of a completed application to the applicant and shall publish a class 2 notice under ch. 985 containing this information in a daily newspaper with general circulation in the area where the proposed project would be located.

SB17,31,22 (b) The commission may group applications for the same or similar types of facilities, services or applications that are proposed, for concurrent review. The commission shall base its review under this paragraph on a comparative analysis of these applications, using the criteria specified in sub. (8) and a ranking of its priorities. The applicant has the burden of proving, by a preponderance of the evidence, that each of the criteria specified in sub. (8) has been met or does not apply to the project. The commission shall, by rule, establish its review requirements under this paragraph.

SB17,32,3 (8) Review criteria. The commission shall use the following criteria in reviewing each application under this section, plus any additional criteria that it develops by rule. The commission shall consider cost containment as its first priority in applying these criteria, and shall consider the recommendations and comments of affected parties. The commission may not approve any project under this section unless the applicant demonstrates all of the following:

SB17,32,4 (a) The project is consistent with the state health services plan under sub. (16).

SB17,32,5 (b) A need for the project, as determined by current and projected utilization.

SB17,32,8 (c) The project would efficiently and economically use resources, including financing for capital investment and operating expenses, when measured against alternative uses of resources.

SB17,32,9 (d) Sufficient cash reserves and cash flow to pay operating and capital costs.

SB17,32,13 (e) Increases in operating and capital costs resulting from the project are reasonable, including the direct charge to the consumer and the charges to be paid by medical assistance and by disability insurers. The commission shall determine the effect on these rates of the applicant's project for review under this paragraph.

SB17,32,14 (f) Financing is available at market rates.

SB17,32,15 (g) Health care personnel are available and would be effectively used.

SB17,32,16 (h) Proposed construction costs are consistent with industry averages.

SB17,32,18 (j) Any proposed addition of area and construction or renovation alternatives are cost-effective.

SB17,32,19 (k) The project is consistent with efficiency standards and criteria.

SB17,32,25 (L) The applicant is participating in a utilization review program that is applicable to a statistical sampling of all hospital patients regardless of payment source, that requires public disclosure of all review data in a form useful to the commission but protects the identities of individual patients and health care professionals and that is conducted by persons who are free from any substantial conflict of interest.

SB17,33,2 (m) The applicant has prepared a plan acceptable to the commission for the provision of health care to indigents.

SB17,33,7 (9) Review process. (a) The commission shall hold a public meeting upon the request of an affected party to review projects seeking approval, at which all affected parties may present testimony. The commission may consider projects seeking approval that are within a related area at joint public meetings. The commission shall keep minutes or other record of testimony presented at the public meeting.

SB17,33,18 (b) The commission shall issue an initial finding to approve or reject the project within 75 days after the date that it publishes its notice under sub. (7) (a), unless all applicants consent to an extension of this period. The commission may not require substantial modification of any project as a condition of approval without the applicant's consent. The commission may extend by 60 days the review cycle of all projects being reviewed concurrently under sub. (7) (b), if it finds that completing the reviews within 75 days after the date it publishes its notice under sub. (7) (a) is not practicable due to the volume of applications received. The commission shall submit its decision to the applicant. Unless the applicant makes a timely request for a hearing under par. (c), the commission's initial finding under this paragraph is its final action.

SB17,33,24 (c) 1. Any applicant whose project is rejected may request a public hearing to review the commission's initial finding under par. (b), if the request is submitted in writing within 10 days after the commission's decision, or may initiate a hearing under s. 227.42. The commission shall commence the hearing under par. (b) within 30 days after receiving a timely request, unless all parties consent to an extension of this period.

SB17,34,3 2. Except as provided in s. 227.42, ss. 227.43 to 227.50 do not apply to hearings under this paragraph. The commission shall promulgate rules to establish all of the following:

SB17,34,4 a. Procedures for scheduling hearings under this paragraph.

SB17,34,7 b. Procedures for conducting hearings under this paragraph, including methods of presenting arguments, cross-examination of witnesses and submission of exhibits.

SB17,34,9 c. Procedures following the completion of a hearing under this paragraph, including the establishment of time limits for issuance of a decision.

SB17,34,11 d. Standards relating to ex parte communication in hearings under this paragraph.

SB17,34,12 e. Procedures for reconsideration and rehearing.

SB17,34,13 3. The commission shall issue all decisions in writing.

SB17,34,17 4. Each applicant at any hearing under this paragraph has the burden of proving, by clear and convincing evidence, that the commission's initial finding was contrary to the weight of the evidence on the record when considered as a whole, arbitrary and capricious or contrary to law.